49 rhizobia strains,isolated from root nodules of broadbean(Vicaia faba L.) in 11 provinces of China were studied by analysis of 138 phenotypic characteristics.All the strains collected together at the boundary of 59% similarity.At the similarity of 80% there were 6 groups which were all composed of strains isolated from the root nodules of broadbean except the cluster 4 included one reference strain.Based on the results of numerical taxonomy,25 strains as the representation of the broadbean rhizobia with 11 reference strains were selected to PCR-RFLP of 16S rDNA analysis.The strains were clustered into 4 groups at the similarity of 85% with another 1 unattached embranchment.The cluster status of 16S rDNA PCR-RFLP was in good agreement with that of numerical taxonomy on the similarity level of 80%.Overall the results demonstrated a high phenotypic and phylogenetic diversity of rhizobia strains nodulating broadbean.

By summarizing the clinical use of different capsule endoscopes in small intestine,colon,stomach and esophagus,the relevant evaluation indicators of the clinical application of capsule endoscopes for patients with different diseases were sorted out.Combined with the review process of capsule endoscopes that have been marketed at home and abroad,the key points of clinical evaluation of capsule endoscopes products in China that need to be marketed through clinical trials were considered.The clinical evaluation focuses included main evaluation index,secondary evaluation index and safety evaluation index,and the main evaluation index could consider the consistency rate of lesion diagnosis results and the excellent rate of image quality.The inclusion criteria for clinical trials of capsule endoscopy products were the population who intended to use the product,and the exclusion criteria need to consider the circumstances that were not applicable to such products and the circumstances that were not applicable to enrollment.